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This study investigated the effect of accumulated doses on radio-photoluminescence glass
dosimeters (RPLGDs) from measurements involving mega-voltage photons.
Methods
Forty-five commercially available RPLGDs were irradiated to estimate their dose responses.
Photon beams of 6, 10, and 15 MV were irradiated onto the RPLGDs inside a phantom,
which were divided into five groups with different doses and energies. Groups 1 and 2 were
irradiated at 1, 5, 10, 50, and 100 Gy in a sequential manner; Group 3 was irradiated 10
times with a dose of 10 Gy; and Groups 4 and 5 followed the same method as that of Group
3, but with doses of 50 Gy and 100 Gy, respectively. Each device was subjected to a mea-
surement reading procedure each time irradiation.
Results
For the annealed Group 1, RPLGD exhibited a linearity response with variance within 5%.
For the non-annealed Group 2, readings demonstrated hyperlinearity at 6 MV and 10 MV,
and linearity at 15 MV. Following the 100 Gy irradiation, the readings for Group 2 were 118.7
± 1.9%, 112.2 ± 2.7%, and 101.5 ± 2.3% at 6, 10, and 15 MV, respectively. For Groups 3, 4,
and 5, the responsiveness of the RPLGDs gradually decreased as the number of repeated
irradiations increased. The percentage readings for the 10th beam irradiation with respect to
the readings for the primary beam irradiation were 84.6 ± 1.9%, 87.5 ± 2.4%, and 93.0 ±
3.0% at 6 MV, 10 MV, and 15 MV, respectively.
Conclusions
The non-annealed RPLGD response to dose was hyperlinear for the 6 MV and 10 MV pho-
ton beams but not for the 15 MV photon beam. Additionally, the annealed RPLGD exhibited
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a fading phenomenon when the measurement was repeated several times and demon-
strated a relatively large fading effect at low energies than at high energies.
Background
Radiation therapy, along with surgery and chemotherapy, plays a critical role as a main treat-
ment approach for cancer patients [1, 2]. Furthermore, radiation therapy trends are shifting
from traditional three-dimensional conformal radiation therapy (3DCRT) techniques to com-
plex radiation delivery techniques, such as intensity-modulated radiation therapy (IMRT), vol-
umetric modulated arc therapy (VMAT), and helical tomotherapy (TOMO), all of which
deliver more precise and localized dose distributions [3, 4]. Because radiation therapy tech-
niques have become more complex and sophisticated, the importance of proper quality control
(QC) and quality assurance (QA) for precise patient care has increased [5–7], thereby increas-
ing the importance of accurate in vivo and phantom dose measurements.
In vivo measurement is an important procedure for verifying that, during treatment, a radi-
ation dose has irradiated the patient accurately according to the treatment plan. In vivo mea-
surements are performed at several locations, with these measurements requiring high spatial
resolution, high sensitivity, and low dose influence, over a broad range of doses. Silicon diodes,
Gafchromic films, metal–oxide–semiconductor field-effect transistors (MOSFETs), and ther-
moluminescence detectors (TLDs) are all currently used as in vivo dosimetric tools [8–14].
These sensors each have their own inherent advantages and disadvantages. TLDs have advan-
tages, such as small detector size, good reproducibility, and radiation sensitivity, but also have
disadvantages in terms of angular dependence, energy dependence, and relatively large work-
loads in calibration and measurement procedures [15]. In comparison with TLDs, diodes and
MOSFETs, have an advantage in terms of eliciting immediate responses, but these detectors
have relatively high initial costs, and exhibit fading effects after dose limitations [8]. Mean-
while, external beam therapy 3 (EBT3) film, the representative Gafchromic film that is cur-
rently in use, has an advantage in terms of being thin, and also permits two-dimensional dose
distribution; however, it has a relatively long saturation time, and exhibits high uncertainty at
low doses [10]. In 1999, the optically stimulated luminescence dosimeter (OSLD) was intro-
duced by McKeever et al.; it comprises crystalline aluminum oxide doped with carbon (Al2O3:
C), and is characterized by high radiation sensitivity, good dose linearity, and a low effective
atomic number, and does not suffer from fading [16]. Although they suffer signal losses of
1–2%, OSLDs have an advantage in terms of allowing repeat readings, accumulated readings,
sensor identification QR codes, having relatively short reading procedures (~10 min), and hav-
ing simple read outs that use light instead of heat, which reduces the risk of damage to the
detectors. With these advantages, the OSLD is rapidly becoming important in the field of in
vivo dosimetry [17].
A commercially available radio-photoluminescence glass dosimeter (RPLGD, GD-302M,
Asahi Techno Glass Co., Shizuoka, Japan) has been introduced in Japan as an alternative to
TLDs. The RPLGD has relatively good reproducibility and exhibits low energy dependence at
energies higher than 200 keV. Additionally, the rod-shaped RPLGD, which has a round cross
section, may have a relatively small incident-beam angular dependence on the orthogonal
direction of the sensor. In comparison with TLDs or OSLDs, the RPLGD has the advantage of
being easy and safe to use inside the human body, because of its low toxicity and thin rod
shape. Similar to OSLDs, RPLGDs are advantageous in that they allow repeat readings, accu-
mulated readings, sensor identification numbers, have relatively short reading procedures, and
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use the same simple read outs as those of OSLDs [18, 19]. In 2009, Lee et al. presented the dosi-
metric characteristics and performance of the RPLGD for environmental exposure situations
[20]. They found that the RPLGD fading was approximately 1% within 30 days of being
exposed to approximately 0.6, 6, and 20 mGy. Meanwhile, in a later study in 2019, Shehzadi
et al. discovered, via a repeatability test, that the obtainable statistical uncertainty of the
RPLGD was within 1% [21]. They estimated the amount of deviation in the RPLGD reading
after irradiation with approximately 1, 3, 5, and 9 Gy using a therapy-level Co-60 gamma ray
beam.
In recent years, RPLGDs have become important in the field of in vivo dosimetry. However,
no study on the accumulative dose response of RPLGDs has been conducted thus far. There-
fore, in this study, we evaluated and reported on the accumulated dose response of RPLGDs
for mega-voltage therapeutic X-ray beams.
Methods
RPLGD
The commercially available RPLGD used in this study (GD-302M, Asahi Techno Glass Co.,
Shizuoka, JAPAN) was a colorless and transparent glass rod with a diameter of 0.15 cm and a
length of 1.20 cm. The by-weight composition of the RPLGD was 51.16% of O, 31.55% of P,
11.00% of Na, 6.12% of Al, and 0.17% of Ag [22]. The density and effective atomic number of
RPLGD were 2.61 g/cm3 and 12.039, respectively [22]. The RPLGD used had a thin plastic
cover that was 0.28 cm in diameter and 1.30 cm in length. A dose estimate for the RPLGD in
the reader (FGD-1000; Asahi Techno Glass Co., Shizuoka, Japan) was performed via measure-
ment of the stimulated emission of orange light (500–700 nm) from the dosimeter when a
365-nm mono-energetic laser was exposed on the irradiated dosimeter. The readout process is
as follows; (I) Annealing for removal of residual signal from RPLGD using an electric furnace
(400˚C for 1 hour) (II) reading the initial dose value for debris, speckle or cloud inspection
(III) beam irradiation (IV) preheating (70˚C for 30 minutes) to bring the electron to the cor-
rect color center and to stabilize the luminescent signal of the RPLGD before reading, (V) read
out. If cumulative dose measurements are desired, previous readings can be preserved by not
performing an annealing process. During dose readout, there were two readout modes, based
on dose values: low-dose-range mode (10 μGy–10 Gy), and high-dose-range mode (1–500
Gy). In this study, we used the high-dose-range mode.
Experimental measurements
Fig 1 illustrates the experimental setup. Forty-five RPLGDs were irradiated on a 10 × 10 cm2
open field, using 6, 10, and 15 MV photon beams. The source-to-surface distance (SSD) was
100 cm, and the depths of the detectors were set relative to the dose-maximum depth of
energy: 1.5 cm (6 MV), 2.5 cm (10 MV), and 3.0 cm (15 MV). A 20-cm-thick block of water-
equivalent solid phantom was placed behind the detectors to gather the backscatter of radia-
tion. A 1-cm-thick homemade RPLGD phantom was inserted between the build-up phantom
and backscatter phantom. Although the phantom was designed to contain up to 42 RPLGDs,
in this study, only 3 RPLGDs were inserted at a time into the homemade phantom to be irradi-
ated with radiation. For accurate dose delivery, the monitor unit (MU) value was corrected,
considering the output factor of the linear accelerator measured according to TRS-398 [23]
and the percentage depth dose (PDD) of the beam data.
For each energy level, five groups were created, wherein each group involved three detec-
tors and its own set of experimental conditions. For most of the groups, except Group 2, the
detectors were initialized each time by being annealed at 400˚C for 1 h before each irradiation.
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For Group 2, the annealing process was skipped during the measurements to evaluate the effect
of the annealing process. Groups 1 and 2 were irradiated to values of 1 Gy, 5 Gy, 10 Gy, 50 Gy,
and then 100 Gy, in order; readings were taken after each irradiation to estimate the dose read-
out for the integral dose, with (Group 1) and without (Group 2) the annealing procedure. For
Group 3, the RPLGD reading procedure was performed after irradiation with a dose of approxi-
mately 10 Gy. This procedure was repeated 10 times to evaluate the fading effect of RPLGD. For
Groups 4 and 5, the RPLGD reading procedure was conducted after irradiation with 50 Gy
(Group 4) and 100 Gy (Group 5). In the same way as with Group 3, these procedures were
repeated 10 times for each group at three different levels of energy: 6, 10, and 15 MV.
Results
Fig 2 depicts the measurement results for Groups 1 (dashed line) and 2 (solid line). For each
run with Group 1, the setup was annealed at 400˚C for 1 h before each irradiation. The anneal-
ing process was skipped for Group 2. Each group was irradiated to 1, 5, 10, 50, and 100 Gy, in
order. The energies of the irradiated beam were (a) 6 MV (open circles: annealed; shaded cir-
cles: accumulated), (b) 10 MV (open triangles: annealed; shaded triangles: accumulated), and
(c) 15 MV (open squares: annealed; shaded squares: accumulated). Fig 2(D) depicts the dose
ratios of measurements and irradiation doses. The solid red lines in Fig 2(A), 2(B) and 2(C)
represent the expected values when the reading of RPLGD increases in proportion to the irra-
diation dose. Group 2 exhibits a hyperlinear response, as depicted in Fig 2. In Group 1, when
the doses were sequentially increased to 1, 5, 10, 50, and 100 Gy over a total of 5 times, the
Fig 1. Measurement setup. (a) Beam irradiation setup (SSD: 100 cm, field size: 10 × 10 cm2, Depth: Dmax), (b) Homemade RPLGD
phantom.
https://doi.org/10.1371/journal.pone.0234829.g001
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dose response (dashed black line) did not exhibit a significant difference in comparison with
the expected value (solid red line); however, in Group 2, the dose response (solid black line)
was higher overall. Table 1 presents the percentages of the measured values relative to the irra-
diation doses for Groups 1 and 2. The top three rows list the results for Group 1, wherein the
Fig 2. Measurement results for Group 1 (dashed line) and Group 2 (solid line). For each run with Group 1, the setup is annealed at
400˚C for 1 h before each irradiation. The annealing process is skipped for Group 2. Each group is irradiated to 1, 5, 10, 50, and 100 Gy, in
order. The energies of the irradiated beam are (a) 6 MV (open circles: annealed; shaded circles: accumulated), (b) 10 MV (open triangles:
annealed; shaded triangles: accumulated), and (c) 15 MV (open squares: annealed; shaded squares: accumulated). (d) Dose ratios of
measurements and irradiation doses.
https://doi.org/10.1371/journal.pone.0234829.g002
Table 1. Measurement results for Groups 1 and 2.
Annealing Energy (MV) Exposed Dose (Gy)
1 5 10 50 100
Yes (Group 1) 6 100.0 ± 0.5 98.6 ± 0.4 101.4 ± 0.3 96.2 ± 0.3 104.0 ± 0.3
10 100.0 ± 1.6 99.9 ± 0.9 102.4 ± 1.4 97.3 ± 0.9 104.6 ± 1.9
15 100.0 ± 1.0 102.7 ± 1.9 97.0 ± 1.5 92.9 ± 2.3 95.0 ± 2.6
No (Group 2) 6 100.0 ± 0.3 99.0 ± 0.9 102.4 ± 0.8 98.7 ± 3.1 118.7 ± 1.9
10 100.0 ± 0.9 94.8 ± 0.8 98.9 ± 0.8 98.1 ± 0.2 112.2 ± 2.7
15 100.0 ± 0.7 102.3 ± 1.0 90.1 ± 2.4 93.3 ± 1.4 101.5 ± 2.3
The top three rows list the results for Group 1, wherein the setup is initialized each time by being annealed at 400˚C for 1 h before each irradiation. The bottom three
rows list the results for Group 2, wherein the setup is not annealed. The irradiation dose is sequentially increased to 1, 5, 10, 50, and 100 Gy, over a total of five steps.
https://doi.org/10.1371/journal.pone.0234829.t001
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setup was initialized each time by being annealed at 400˚C for 1 h before each irradiation.
Meanwhile, the bottom three rows list the results for Group 2, wherein the setup was not
annealed. In the case of Group 1, the percentage of the measured value relative to the beam
irradiation was estimated to be within 5%, whereas for Group 2, the percentages of the mea-
sured values relative to the beam irradiation were 118.7 ± 1.9% for 6 MV, 112.2 ± 2.7% for 10
MV, and 101.5 ± 2.3% for 15 MV.
Fig 3 depicts the measurement results for (a) Groups 3, (b) 4, and (c) 5, assuming that the
RPLGDs were reused for similar doses over time. In the experiment, wherein the sequence of ini-
tialization, beam irradiation, and reading was repeated 10 times, the responsiveness of the RPLGD
gradually decreased as the number of repetitions increased. Table 2 presents the measurement
results with respect to the number of irradiation and reading procedures, from 1 to 10 times. Each
group was irradiated at doses of 10, 50, and 100 Gy, with three different energies, namely, 6, 10,
and 15 MV. The values are normalized percentages with respect to the 1st measurement values.
The measurement results after 10 repeated the beam irradiation and reading procedures were
84.6 ± 1.9%, 87.5 ± 2.4%, and 93.0 ± 3.0% at 6 MV, 10 MV, and 15 MV, respectively.
Discussion
The advantages of the RPLGD, in comparison with the TLD, include its good reproducibility
(1%) and relatively low energy dependency at energies higher than 200 keV [24–26].
Fig 3. Measurement results for Groups 3, 4, and 5. Sensors are assumed to have been reused for similar doses over time. Groups 3, 4,
and 5 are irradiated at doses of (a) 10 Gy, (b) 50 Gy, and (c) 100 Gy, respectively. Each group is irradiated with three different energies:
6 MV (solid line), 10 MV (dashed line), and 15 MV (dash-dotted line).
https://doi.org/10.1371/journal.pone.0234829.g003
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Additionally, in comparison with the TLD or OSLD, the RPLGD has a smaller incident-beam-
angle dependency and lower toxicity inside the human body [27–30]. The RPLGD is compara-
ble to the Al2O3:C OSLD, which is made of a luminescent material similar to that of TLD, but
has a different excitation source and uses a different readout technique. The OSLD is not nec-
essary for the heating procedure, but its detector is affected by visible light. A variety of studies
have attempted to characterize the dose response of OSLD; the supra-linearity of the dose
response has been reported to be above 300 cGy, with angular dependency and relatively low
energy dependency, when a clinical mega-voltage photon and electron beam were used [30].
In 2010, Jursinic reported that the OSLD response to dose was supralinear when the detector
received accumulative doses, and that a dose response accuracy of ±0.5% could be achieved if
the sensitivity and extent of supra-linearity were established for each OSLD [31].
Fig 2 depicts that, up to a 50 Gy irradiation, the dose response was not significantly differ-
ent; however, after a 100 Gy irradiation, the response in Group 2 increased to 118%. Thus,
when measured with the RPLGD, the dosimeter response was not proportional to the irradia-
tion dose and exhibited a hyperlinear pattern that resulted in a slightly higher reading when
the setup was cumulatively irradiated without annealing. Additionally, the hyperlinear
response of Group 2 did not appear significantly until the setup was irradiated with 50 Gy, but
exhibited a significant increase in dose response by up to 118% when the setup was irradiated
with 100 Gy. As presented in Table 1, in the case of Group 1, the percentage of the measured
value relative to beam irradiation was estimated to be within 5%, whereas for Group 2, the per-
centages of the measured values relative to beam irradiation were 118.7 ± 1.9% for 6 MV,
112.2 ± 2.7% for 10 MV, and 101.5 ± 2.3% for 15 MV.
Furthermore, the changing effect in dose response due to dose accumulation was also
dependent on beam energy. As shown in Fig 2 and Table 1, the data for the 15 MV beam dose
do not exhibit hyperlinearity in both the annealed (Group 1) and accumulated (Group 2)
cases. Table 3 presents the fitting results for the annealed (Group 1) and accumulated (Group
2) cases via the least square function and quadratic polynomial function. Data fitting was per-
formed using SigmaPlot (Sigmaplot version 14.0, Systate Software, Inc. San Jose, CA 95131,
USA) with the Shapiro–Wilk fitting evaluation tool. For the annealed (Group 1) case, the P val-
ues obtained from the Shapiro–Wilk test for most of the data were greater than 0.05 with the
least square function. For the non-annealed (Group 2) case, the P values for the 6 MV and 10
Table 2. Measurement result of 10 times of beam irradiation and reading to evaluate the fading effect of RPLGD.
Energy (MV) Dose (Gy) Sequence
1 2 3 4 5 6 7 8 9 10
6 10 100.0 ± 0.0 97.3 ± 1.2 97.6± 2.0 96.5 ± 0.9 102.0 ± 1.8 96.0 ± 2.4 90.4 ± 1.4 87.6 ± 1.9 86.1 ± 1.0 85.9 ± 2.1
50 100.0 ± 0.0 96.6 ± 0.5 96.9 ± 0.7 94.9 ± 0.4 98.2 ± 0.5 95.1 ± 0.6 92.6 ± 1.7 85.8 ± 0.8 85.7 ± 2.0 83.5 ± 1.0
100 100.0 ± 0.0 94.6 ± 1.6 95.8 ± 1.5 94.9 ± 0.8 97.2 ± 1.9 92.3 ± 2.4 88.1 ± 1.7 85.7 ± 2.8 82.6 ± 2.1 84.4 ± 1.8
10 10 100.0 ± 0.0 100.4 ± 1.0 98.8 ± 0.6 98.4 ± 0.7 99.4 ± 2.2 91.3 ± 0.5 98.1 ± 2.0 90.1 ± 1.9 88.5 ± 2.5 88.2 ± 2.4
50 100.0 ± 0.0 100.3 ± 1.5 98.9 ± 0.7 98.4 ± 0.9 100.1 ± 0.5 94.7 ± 1.0 99.0 ± 0.9 90.3 ± 0.3 89.2 ± 0.5 89.0 ± 1.1
100 100.0 ± 0.0 97.6 ± 1.7 96.0 ± 2.5 95.7 ± 0.3 97.7 ± 0.9 95.7 ± 0.9 90.7 ± 0.7 88.3 ± 1.1 85.5 ± 0.1 85.4 ± 1.7
15 10 100.0 ± 0.0 100.1 ± 1.8 96.9 ± 4.0 91.4 ± 4.0 90.3 ± 1.5 93.1 ± 2.9 98.2 ± 2.8 93.4 ± 3.4 92.8 ± 2.7 92.1 ± 1.8
50 100.0 ± 0.0 99.7 ± 0.7 98.1 ± 0.9 95.5 ± 0.4 95.2 ± 0.5 95.5 ± 1.3 97.0 ± 1.4 96.7 ± 0.5 94.2 ± 2.1 95.1 ± 1.7
100 100.0 ± 0.0 98.4 ± 1.6 98.5 ± 1.1 94.4 ± 1.5 94.9 ± 0.7 94.5 ± 1.6 92.8 ± 1.7 96.6 ± 2.1 93.1 ± 2.0 92.0 ± 3.9
RPLGDs are assumed to have been reused for similar doses over time. Each group is irradiated at doses of 10, 50, and 100 Gy, with three different energies, namely, 6,
10, and 15 MV. The values are normalized percentages with respect to the 1st measurement values.
https://doi.org/10.1371/journal.pone.0234829.t002
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MV data were lesser than 0.05 with the least square function. For the 15 MV non-annealed
data (Group 2), the P value from the Shapiro–Wilk test was 0.6429.
The fitting results also demonstrated that the dose response for the annealed case (Group 1)
was linear with respect to the irradiation dose. For the non-annealed case (Group 2), the 6 MV
and 10 MV data exhibited a hyperlinear dose response, whereas the 15 MV data exhibited a
linear response. Therefore, when measurements are being conducted using RPLGD, particu-
larly in the case of measurements at low energies with high doses, it is suggested that the
annealing process be performed each time to reduce errors due to dose accumulation. In con-
trast, it is possible to correct the data response by considering the hyperlinearity of RPLGD
through the use of a fitting parameter. In the results for Groups 1 and 2, the dispersion
between the measuring elements was measured to be within 3%. Therefore, given that, the dif-
ference between the sensors is small in the measurement, it is possible to correct the read dose
value via acquisition of factors related to the cumulative dose response of each detector with
respect to energy, rather than via initialization of the detector every time before measurement.
Fig 3 depicts that the responsiveness of the RPLGD gradually decreases to approximately –
15% as the number of repetitions increases. This fading phenomenon is more prominent at
lower energies than at higher energies. However, a significant relationship does not appear to
exist between the magnitude of the dose irradiated to the detectors and the fading effect. As
presented in Table 4, the fading slope obtained via a least square fit was largest at 6 MV and
smallest at 15 MV. The measurement results after 10 repeated beam irradiations were
Table 4. Fitting results for fading slope, intercept, and error obtained via least square fit.
Dose (Gy) 10 (Group 3) 50 (Group 4) 100 (Group 5)
Energy (MV) Slope Intercept Error Slope Intercept Error Slope Intercept Error
6 −1.723 102.698 0.661 −1.879 102.497 0.768 −2.047 102.243 0.768
10 −1.663 103.840 0.686 −1.439 103.342 0.716 −1.521 100.688 0.831
15 −0.682 98.866 0.056 −0.497 99.661 0.586 −0.761 99.608 0.605
These results are for three values of energy and three values of dose. Groups 3, 4, and 5 are irradiated with doses of 10, 50, and 100 Gy, respectively. Each group is
irradiated at three different energies (6, 10, and 15 MV).
https://doi.org/10.1371/journal.pone.0234829.t004
Table 3. Fitting results for Groups 1 and 2.
Energy (MV) Annealing Process Fitting Function y0 a b R
2 STD Error Shapiro–Wilk (P > 0.05)
6 Yes Least square 0.4382 1.0000 – 0.9975 2.1775 0.1731
2nd Poly 0.5653 0.8758 0.0016 0.9998 0.5829 0.5182
No Least square 3.6384 1.0000 – 0.9713 8.4095 0.0005
2nd Poly 1.0176 0.7714 0.0040 0.9996 0.9937 0.6804
10 Yes Least square 0.6996 1.0000 – 0.9973 2.2882 0.0570
2nd Poly 0.5413 0.8913 0.0015 0.9998 0.5630 0.6158
No Least square 2.1819 1.0000 – 0.9857 5.639 0.0010
2nd Poly 0.6074 0.8298 0.0029 0.9998 0.6088 0.4727
15 Yes Least square −1.1926 1.0000 – 0.9944 2.9737 0.0031
2nd Poly 0.4383 0.8989 0.0005 0.9999 0.327 0.0607
No Least square −0.5494 1.0000 – 0.9982 1.8029 0.6429
2nd Poly 0.4868 0.8382 0.0017 0.9999 0.3636 0.5408
Group 1 is initialized each time via annealing at 400˚C for 1 h before each irradiation, whereas Group 2 is not annealed. The irradiation dose is sequentially increased to
1, 5, 10, 50, and 100 Gy, over a total of five steps. The least squares function and quadratic polynomial function are used as fitting functions for the measurement results.
https://doi.org/10.1371/journal.pone.0234829.t003
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84.6 ± 1.9%, 87.5 ± 2.4%, and 93.0 ± 3.0%, at 6 MV, 10 MV, and 15 MV, respectively. However,
until the fifth measurement in the overall measurement process, the fading effect was insignifi-
cant, being within 5%. Therefore, if possible, recalibrating the RPLGD after five uses is neces-
sary to correct the sensitivity degradation due to the fading effect. Although correcting the
measured value by considering the effect of fading on each RPLGD is possible at each energy
level, in this case, the similarity of the dose responses among the RPLGDs should be evaluated.
In this study, measurements were performed using three detectors in each group; however,
more detailed results can be obtained through the use of a greater number of glass dosimeters
to reduce the statistical uncertainty in the near future.
Conclusions
The non-annealed RPLGD response to dose was determined to be hyperlinear for the 6 MV
and 10 MV photon beams but not for the 15 MV photon beam. This response was also found
to change according to the amount of accumulated dose delivered to the RPLGD. Additionally,
the annealed RPLGD was observed to exhibit a fading phenomenon when the measurement
was repeated several times, and the fading effect was relatively significant at low energies in
comparison with high energies. In this study, measurements were performed using only three
detectors in each group; however, more detailed results and predictions for the responses can
be obtained in the near future through the use of a greater number of glass dosimeters to
reduce statistical uncertainty. Moreover, after up to five repeated uses, the calibration of each
detector needs to be performed to reduce the uncertainty caused by the fading effect. Further-
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